NCPA

New Report: PBMs Push Drug Costs
New Report: PBMs Push Drug CostsAre PBMs responsible for higher drug prices or is something else to blame?
Why This PBM Comparison Is a Bit of a WhopperAre pharmacies really comparable to fast-food outlets?
Keep prescription drug benefits in ACA, NCPA urgesNCPA sends letter to Senate on prescription issues in health-care reform.
Reader Response
5 Ways to Improve Medicare Part DNCPA’s recommendations for improving the “increasingly complicated Part D marketplace.”
Pharmacists Are Flying In to Washington to Talk and PersuadeDIR fees top pharmacy legislator meetings.
Surescripts Takes Aim at Improving e-Prescribing AccuracyNew monitoring system identifies problems with e-prescription systems.
Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
The Top Six Ways Trump’s Policies Will Impact Pharmacies
The Top Six Ways Trump’s Policies Will Impact PharmaciesHow the new Trump administration will affect everything from the ACA to the FDA.